BofA/Merrill Lynch Upgrades Integra LifeSciences (IART) to Buy
Get Alerts IART Hot Sheet
Price: $28.34 -0.25%
Rating Summary:
10 Buy, 14 Hold, 2 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 22 | Down: 21 | New: 11
Rating Summary:
10 Buy, 14 Hold, 2 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 22 | Down: 21 | New: 11
Join SI Premium – FREE
BofA/Merrill Lynch upgraded Integra LifeSciences (NASDAQ: IART) from Neutral to Buy with a price target of $79.00.
For an analyst ratings summary and ratings history on Integra LifeSciences click here. For more ratings news on Integra LifeSciences click here.
Shares of Integra LifeSciences closed at $64.23 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CFRA Upgrades Persimmon Plc. (PSN:LN) (PSMMY) to Buy
- CLSA Upgrades Nippon Prologis REIT Inc. (3283:JP) (NPONF) to Buy (1)
- Monness, Crespi, Hardt Upgrades Palantir Technologies (PLTR) to Neutral ahead of earnings report
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!